{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:29:01Z","timestamp":1792718941048,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["GOSOMICS; BRD; 4960"],"award-info":[{"award-number":["GOSOMICS; BRD; 4960"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13024-015-0059-y","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:38:56Z","timestamp":1448930336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay"],"prefix":"10.1186","volume":"10","author":[{"given":"Wendy E.","family":"Heywood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestas","family":"Sirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross W.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Magdalinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Carecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fenoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Bahtia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"59_CR1","unstructured":"Prince PM, Guerchet DM, Prina DM, International AsD. Policy brief: the global impact of dementia 2013\u20132050. http:\/\/www.alz.co.uk\/research\/G8-policy-brief : Alzheimers Disease International. 2013."},{"issue":"4","key":"59_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010. J Neuropathol Exp Neurol. 2012;71(4):266\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"59_CR3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/jnnp-2014-307662","volume":"85","author":"RM Ahmed","year":"2014","unstructured":"Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O\u2019Brien JT, Fox NC, et al. Biomarkers in dementia: clinical utility and new directions. J Neurol Neurosurg Psychiatry. 2014;85(12):1426\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.27.Suppl_8.64","volume":"8","author":"F Hoof Van","year":"1974","unstructured":"Van Hoof F. Mucopolysaccharidoses and mucolipidoses. J Clin Pathol Suppl. 1974;8:64\u201393.","journal-title":"J Clin Pathol Suppl"},{"issue":"8","key":"59_CR5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuint.2005.12.005","volume":"48","author":"AM Nilselid","year":"2006","unstructured":"Nilselid AM, Davidsson P, Nagga K, Andreasen N, Fredman P, Blennow K. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem Int. 2006;48(8):718\u201328.","journal-title":"Neurochem Int"},{"issue":"3","key":"59_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/CCLM.2011.083","volume":"49","author":"J Steiner","year":"2011","unstructured":"Steiner J, Bogerts B, Schroeter ML, Bernstein HG. S100B protein in neurodegenerative disorders. Clin Chem Lab Med. 2011;49(3):409\u201324.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"59_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3233\/JAD-2010-1309","volume":"19","author":"C Comi","year":"2010","unstructured":"Comi C, Carecchio M, Chiocchetti A, Nicola S, Galimberti D, Fenoglio C, et al. Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer\u2019s disease and its levels correlate with cognitive decline. J Alzheimers Dis. 2010;19(4):1143\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"59_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-2010-091594","volume":"21","author":"J Sundelof","year":"2010","unstructured":"Sundelof J, Sundstrom J, Hansson O, Eriksdotter-Jonhagen M, Giedraitis V, Larsson A, et al. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer\u2019s disease, mild cognitive impairment, and healthy controls. J Alzheimers Dis. 2010;21(2):471\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"59_CR9","first-page":"1569","volume":"369","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Hardy J. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369(16):1569\u201370.","journal-title":"N Engl J Med"},{"issue":"12","key":"59_CR10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","volume":"71","author":"C Liguori","year":"2014","unstructured":"Liguori C, Romigi A, Nuccetelli M, Zannino S, Sancesario G, Martorana A, et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol. 2014;71(12):1498\u2013505.","journal-title":"JAMA Neurol"},{"issue":"3","key":"59_CR11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, et al. Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol. 2013;9(3):131\u201340.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"59_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-2011-101989","volume":"25","author":"A Barnett","year":"2011","unstructured":"Barnett A, Brewer GJ. Autophagy in aging and Alzheimer\u2019s disease: pathologic or protective? J Alzheimers Dis. 2011;25(3):385\u201394.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"59_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/neur.1995.0052","volume":"4","author":"I Skoog","year":"1995","unstructured":"Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, et al. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration. 1995;4(4):433\u201342.","journal-title":"Neurodegeneration"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2377-14-64","volume":"14","author":"J Hertze","year":"2014","unstructured":"Hertze J, Nagga K, Minthon L, Hansson O. Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer\u2019s disease: an observational study. BMC Neurol. 2014;14:64.","journal-title":"BMC Neurol"},{"issue":"Web Server issu","key":"59_CR15","doi-asserted-by":"crossref","first-page":"W77","DOI":"10.1093\/nar\/gkt439","volume":"41","author":"J Wang","year":"2013","unstructured":"Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT analysis toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013;41(Web Server issue):W77\u201383.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"59_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2008-14102","volume":"14","author":"SF Gloeckner","year":"2008","unstructured":"Gloeckner SF, Meyne F, Wagner F, Heinemann U, Krasnianski A, Meissner B, et al. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J Alzheimers Dis. 2008;14(1):17\u201325.","journal-title":"J Alzheimers Dis"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-9-22","volume":"9","author":"KR Wildsmith","year":"2014","unstructured":"Wildsmith KR, Schauer SP, Smith AM, Arnott D, Zhu Y, Haznedar J, et al. Identification of longitudinally dynamic biomarkers in Alzheimer\u2019s disease cerebrospinal fluid by targeted proteomics. Mol Neurodegener. 2014;9:22.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"59_CR18","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1021\/pr500421v","volume":"13","author":"C Pan","year":"2014","unstructured":"Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, et al. Targeted discovery and validation of plasma biomarkers of Parkinson\u2019s disease. J Proteome Res. 2014;13(11):4535\u201345.","journal-title":"J Proteome Res"},{"issue":"1","key":"59_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nmeth.2285","volume":"10","author":"V Marx","year":"2013","unstructured":"Marx V. Targeted proteomics. Nat Methods. 2013;10(1):19\u201322.","journal-title":"Nat Methods"},{"issue":"2","key":"59_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1373\/clinchem.2013.210948","volume":"60","author":"SJ Moat","year":"2014","unstructured":"Moat SJ, Rees D, King L, Ifederu A, Harvey K, Hall K, et al. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. Clin Chem. 2014;60(2):373\u201380.","journal-title":"Clin Chem"},{"issue":"9","key":"59_CR21","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1074\/mcp.E113.031658","volume":"12","author":"R Aebersold","year":"2013","unstructured":"Aebersold R, Burlingame AL, Bradshaw RA. Western blots versus selected reaction monitoring assays: time to turn the tables? Mol Cell Proteomics. 2013;12(9):2381\u20132.","journal-title":"Mol Cell Proteomics"},{"issue":"1\u20132","key":"59_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2006.02.008","volume":"400","author":"K Umemura","year":"2006","unstructured":"Umemura K, Yamashita N, Yu X, Arima K, Asada T, Makifuchi T, et al. Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci Lett. 2006;400(1\u20132):97\u2013100.","journal-title":"Neurosci Lett"},{"issue":"1","key":"59_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2012.09.010","volume":"1832","author":"J Shi","year":"2013","unstructured":"Shi J, Dong Y, Cui MZ, Xu X. Lysophosphatidic acid induces increased BACE1 expression and Abeta formation. Biochim Biophys Acta. 2013;1832(1):29\u201338.","journal-title":"Biochim Biophys Acta"},{"issue":"52","key":"59_CR24","doi-asserted-by":"crossref","first-page":"37046","DOI":"10.1074\/jbc.274.52.37046","volume":"274","author":"CL Sayas","year":"1999","unstructured":"Sayas CL, Moreno-Flores MT, Avila J, Wandosell F. The neurite retraction induced by lysophosphatidic acid increases Alzheimer\u2019s disease-like Tau phosphorylation. J Biol Chem. 1999;274(52):37046\u201352.","journal-title":"J Biol Chem"},{"issue":"1","key":"59_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2012-120439","volume":"31","author":"SH Hwang","year":"2012","unstructured":"Hwang SH, Shin EJ, Shin TJ, Lee BH, Choi SH, Kang J, et al. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer\u2019s disease-related neuropathies: involvement of non-amyloidogenic processing. J Alzheimers Dis. 2012;31(1):207\u201323.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"59_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12017-013-8269-3","volume":"16","author":"A Armstrong","year":"2014","unstructured":"Armstrong A, Mattsson N, Appelqvist H, Janefjord C, Sandin L, Agholme L, et al. Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer\u2019s disease. Neuromolecular Med. 2014;16(1):150\u201360.","journal-title":"Neuromolecular Med"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2014.09.050","volume":"302","author":"LF Lue","year":"2014","unstructured":"Lue LF, Schmitz C, Walker DG. What happens to microglial TREM2 in Alzheimer\u2019s disease: Immunoregulatory turned into immunopathogenic? Neuroscience. 2014;302:138\u201350. doi: 10.1016\/j.neuroscience.2014.09.050 .","journal-title":"Neuroscience"},{"issue":"4","key":"59_CR28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bpa.12190","volume":"25","author":"LF Lue","year":"2014","unstructured":"Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG. TREM2 protein expression changes correlate with Alzheimer\u2019s disease neurodegenerative pathologies in post-mortem temporal cortices. Brain Pathol. 2014;25(4):469\u201380. doi: 10.1111\/bpa.12190 .","journal-title":"Brain Pathol"},{"issue":"Pt 11","key":"59_CR29","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","volume":"131","author":"L Piccio","year":"2008","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain. 2008;131(Pt 11):3081\u201391.","journal-title":"Brain"},{"issue":"2","key":"59_CR30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymeth.2011.12.009","volume":"56","author":"K Poulsen","year":"2012","unstructured":"Poulsen K, Bahl JM, Tanassi JT, Simonsen AH, Heegaard NH. Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein. Methods. 2012;56(2):284\u201392.","journal-title":"Methods"},{"issue":"4","key":"59_CR31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.63.4.506","volume":"63","author":"JM Serot","year":"1997","unstructured":"Serot JM, Christmann D, Dubost T, Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;63(4):506\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"59_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-510X(96)00234-1","volume":"145","author":"A Merched","year":"1997","unstructured":"Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G. Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer\u2019s disease. J Neurol Sci. 1997;145(1):33\u20139.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"59_CR33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molbrainres.2003.08.005","volume":"118","author":"M Puchades","year":"2003","unstructured":"Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer\u2019s disease. Brain Res Mol Brain Res. 2003;118(1\u20132):140\u20136.","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"59_CR34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/pr301200e","volume":"12","author":"V Manwaring","year":"2013","unstructured":"Manwaring V, Heywood WE, Clayton R, Lachmann RH, Keutzer J, Hindmarsh P, et al. The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients. J Proteome Res. 2013;12(5):2013\u201321.","journal-title":"J Proteome Res"},{"issue":"Pt 3","key":"59_CR35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain. 2010;133(Pt 3):713\u201326.","journal-title":"Brain"},{"issue":"3","key":"59_CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/ene.12326","volume":"21","author":"H Zetterberg","year":"2014","unstructured":"Zetterberg H, Petzold M, Magdalinou N. Cerebrospinal fluid alpha-synuclein levels in Parkinson\u2019s disease--changed or unchanged? Eur J Neurol. 2014;21(3):365\u20137.","journal-title":"Eur J Neurol"},{"issue":"7","key":"59_CR37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"11","key":"59_CR38","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9(11):1118\u201327.","journal-title":"Lancet Neurol"},{"issue":"8","key":"59_CR39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734\u201346.","journal-title":"Lancet Neurol"},{"issue":"5","key":"59_CR40","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1212\/WNL.44.5.872","volume":"44","author":"IG McKeith","year":"1994","unstructured":"McKeith IG, Fairbairn AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology. 1994;44(5):872\u20137.","journal-title":"Neurology"},{"issue":"Suppl","key":"59_CR41","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1002\/ana.410320721","volume":"32","author":"DB Calne","year":"1992","unstructured":"Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol. 1992;32(Suppl):S125\u20137.","journal-title":"Ann Neurol"},{"issue":"3","key":"59_CR42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6(3):131\u201344.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"59_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00365519609088600","volume":"56","author":"F Sellebjerg","year":"1996","unstructured":"Sellebjerg F, Christiansen M. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand J Clin Lab Invest. 1996;56(2):135\u201343.","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"59_CR44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol. 1995;26(3):231\u201345.","journal-title":"Mol Chem Neuropathol"},{"issue":"6","key":"59_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, et al. Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56(6):673\u201380.","journal-title":"Arch Neurol"},{"issue":"6","key":"59_CR46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","volume":"10","author":"FH Duits","year":"2014","unstructured":"Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, et al. The cerebrospinal fluid \u201cAlzheimer profile\u201d: easily said, but what does it mean? Alzheimers Dement. 2014;10(6):713\u201323.e2.","journal-title":"Alzheimers Dement"},{"issue":"1\u20132","key":"59_CR47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.chroma.2005.03.121","volume":"1079","author":"H Toll","year":"2005","unstructured":"Toll H, Oberacher H, Swart R, Huber CG. Separation, detection, and identification of peptides by ion-pair reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry at high and low pH. J Chromatogr A. 2005;1079(1\u20132):274\u201386.","journal-title":"J Chromatogr A"},{"issue":"8","key":"59_CR48","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1021\/pr1003467","volume":"9","author":"K Bennett","year":"2010","unstructured":"Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, Clayman GL, et al. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res. 2010;9(8):4289\u201394.","journal-title":"J Proteome Res"},{"issue":"6","key":"59_CR49","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/pr049882h","volume":"3","author":"R Craig","year":"2004","unstructured":"Craig R, Cortens JP, Beavis RC. Open source system for analyzing, validating, and storing protein identification data. J Proteome Res. 2004;3(6):1234\u201342.","journal-title":"J Proteome Res"},{"issue":"11","key":"59_CR50","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.jprot.2012.03.037","volume":"75","author":"W Heywood","year":"2012","unstructured":"Heywood W, Wang D, Madgett TE, Avent ND, Eaton S, Chitty LS, et al. The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome. J Proteomics. 2012;75(11):3248\u201357.","journal-title":"J Proteomics"}],"updated-by":[{"DOI":"10.1186\/s13024-016-0086-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000}}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0059-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T23:13:30Z","timestamp":1567379610000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.molecularneurodegeneration.com\/content\/10\/1\/64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1186\/s13024-015-0059-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13024-016-0086-3","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"64"}}